Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Milestones in Neuroimaging

Identifieur interne : 000579 ( PascalFrancis/Corpus ); précédent : 000578; suivant : 000580

Milestones in Neuroimaging

Auteurs : A. Jon Stoessl ; David J. Brooks ; David Eidelberg

Source :

RBID : Pascal:11-0264645

Descripteurs français

English descriptors

Abstract

In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 26
A06       @2 6
A08 01  1  ENG  @1 Milestones in Neuroimaging
A11 01  1    @1 STOESSL (A. Jon)
A11 02  1    @1 BROOKS (David J.)
A11 03  1    @1 EIDELBERG (David)
A14 01      @1 Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health @2 Vancouver, British Columbia @3 CAN @Z 1 aut.
A14 02      @1 Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital @2 London @3 GBR @Z 2 aut.
A14 03      @1 Center for Neurosciences, Feinstein Institute for Medical Research @2 Manhasset, New York @3 USA @Z 3 aut.
A20       @1 968-978
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000191622890040
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 197 ref.
A47 01  1    @0 11-0264645
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.
C02 01  X    @0 002B17
C02 02  X    @0 002B24A06
C03 01  X  FRE  @0 Dystonie @5 01
C03 01  X  ENG  @0 Dystonia @5 01
C03 01  X  SPA  @0 Distonía @5 01
C03 02  X  FRE  @0 Chorée de Huntington @5 02
C03 02  X  ENG  @0 Huntington disease @5 02
C03 02  X  SPA  @0 Corea Huntington @5 02
C03 03  X  FRE  @0 Pathologie du système nerveux @5 03
C03 03  X  ENG  @0 Nervous system diseases @5 03
C03 03  X  SPA  @0 Sistema nervioso patología @5 03
C03 04  X  FRE  @0 Dopamine @2 NK @2 FR @5 09
C03 04  X  ENG  @0 Dopamine @2 NK @2 FR @5 09
C03 04  X  SPA  @0 Dopamina @2 NK @2 FR @5 09
C03 05  X  FRE  @0 Tomoscintigraphie @5 10
C03 05  X  ENG  @0 Emission tomography @5 10
C03 05  X  SPA  @0 Tomocentelleografía @5 10
C03 06  X  FRE  @0 Tomographie par émission de positons @5 11
C03 06  X  ENG  @0 Positron emission tomography @5 11
C03 06  X  SPA  @0 Tomografía emisión positrones @5 11
C07 01  X  FRE  @0 Syndrome extrapyramidal @5 37
C07 01  X  ENG  @0 Extrapyramidal syndrome @5 37
C07 01  X  SPA  @0 Extrapiramidal síndrome @5 37
C07 02  X  FRE  @0 Mouvement involontaire @5 38
C07 02  X  ENG  @0 Involuntary movement @5 38
C07 02  X  SPA  @0 Movimiento involuntario @5 38
C07 03  X  FRE  @0 Pathologie du muscle strié @5 39
C07 03  X  ENG  @0 Striated muscle disease @5 39
C07 03  X  SPA  @0 Músculo estriado patología @5 39
C07 04  X  FRE  @0 Trouble neurologique @5 41
C07 04  X  ENG  @0 Neurological disorder @5 41
C07 04  X  SPA  @0 Trastorno neurológico @5 41
C07 05  X  FRE  @0 Pathologie de l'encéphale @5 42
C07 05  X  ENG  @0 Cerebral disorder @5 42
C07 05  X  SPA  @0 Encéfalo patología @5 42
C07 06  X  FRE  @0 Maladie dégénérative @5 43
C07 06  X  ENG  @0 Degenerative disease @5 43
C07 06  X  SPA  @0 Enfermedad degenerativa @5 43
C07 07  X  FRE  @0 Maladie héréditaire @5 44
C07 07  X  ENG  @0 Genetic disease @5 44
C07 07  X  SPA  @0 Enfermedad hereditaria @5 44
C07 08  X  FRE  @0 Pathologie du système nerveux central @5 45
C07 08  X  ENG  @0 Central nervous system disease @5 45
C07 08  X  SPA  @0 Sistema nervosio central patología @5 45
C07 09  X  FRE  @0 Catécholamine @5 46
C07 09  X  ENG  @0 Catecholamine @5 46
C07 09  X  SPA  @0 Catecolamina @5 46
C07 10  X  FRE  @0 Neurotransmetteur @5 47
C07 10  X  ENG  @0 Neurotransmitter @5 47
C07 10  X  SPA  @0 Neurotransmisor @5 47
N21       @1 178
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0264645 INIST
ET : Milestones in Neuroimaging
AU : STOESSL (A. Jon); BROOKS (David J.); EIDELBERG (David)
AF : Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health/Vancouver, British Columbia/Canada (1 aut.); Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital/London/Royaume-Uni (2 aut.); Center for Neurosciences, Feinstein Institute for Medical Research/Manhasset, New York/Etats-Unis (3 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 6; Pp. 968-978; Bibl. 197 ref.
LA : Anglais
EA : In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.
CC : 002B17; 002B24A06
FD : Dystonie; Chorée de Huntington; Pathologie du système nerveux; Dopamine; Tomoscintigraphie; Tomographie par émission de positons
FG : Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Maladie dégénérative; Maladie héréditaire; Pathologie du système nerveux central; Catécholamine; Neurotransmetteur
ED : Dystonia; Huntington disease; Nervous system diseases; Dopamine; Emission tomography; Positron emission tomography
EG : Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Degenerative disease; Genetic disease; Central nervous system disease; Catecholamine; Neurotransmitter
SD : Distonía; Corea Huntington; Sistema nervioso patología; Dopamina; Tomocentelleografía; Tomografía emisión positrones
LO : INIST-20953.354000191622890040
ID : 11-0264645

Links to Exploration step

Pascal:11-0264645

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Milestones in Neuroimaging</title>
<author>
<name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Center for Neurosciences, Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0264645</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0264645 INIST</idno>
<idno type="RBID">Pascal:11-0264645</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000579</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Milestones in Neuroimaging</title>
<author>
<name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Center for Neurosciences, Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Dopamine</term>
<term>Dystonia</term>
<term>Emission tomography</term>
<term>Huntington disease</term>
<term>Nervous system diseases</term>
<term>Positron emission tomography</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Dystonie</term>
<term>Chorée de Huntington</term>
<term>Pathologie du système nerveux</term>
<term>Dopamine</term>
<term>Tomoscintigraphie</term>
<term>Tomographie par émission de positons</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>26</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Milestones in Neuroimaging</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>STOESSL (A. Jon)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>BROOKS (David J.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>EIDELBERG (David)</s1>
</fA11>
<fA14 i1="01">
<s1>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Center for Neurosciences, Feinstein Institute for Medical Research</s1>
<s2>Manhasset, New York</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>968-978</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000191622890040</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>197 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0264645</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B24A06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Chorée de Huntington</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Huntington disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Corea Huntington</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Tomoscintigraphie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Emission tomography</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Tomocentelleografía</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Tomographie par émission de positons</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Positron emission tomography</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Tomografía emisión positrones</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie du muscle strié</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Maladie héréditaire</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Genetic disease</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Enfermedad hereditaria</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Catécholamine</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Catecholamine</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Catecolamina</s0>
<s5>46</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE">
<s0>Neurotransmetteur</s0>
<s5>47</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG">
<s0>Neurotransmitter</s0>
<s5>47</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA">
<s0>Neurotransmisor</s0>
<s5>47</s5>
</fC07>
<fN21>
<s1>178</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0264645 INIST</NO>
<ET>Milestones in Neuroimaging</ET>
<AU>STOESSL (A. Jon); BROOKS (David J.); EIDELBERG (David)</AU>
<AF>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health/Vancouver, British Columbia/Canada (1 aut.); Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital/London/Royaume-Uni (2 aut.); Center for Neurosciences, Feinstein Institute for Medical Research/Manhasset, New York/Etats-Unis (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 6; Pp. 968-978; Bibl. 197 ref.</SO>
<LA>Anglais</LA>
<EA>In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.</EA>
<CC>002B17; 002B24A06</CC>
<FD>Dystonie; Chorée de Huntington; Pathologie du système nerveux; Dopamine; Tomoscintigraphie; Tomographie par émission de positons</FD>
<FG>Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Maladie dégénérative; Maladie héréditaire; Pathologie du système nerveux central; Catécholamine; Neurotransmetteur</FG>
<ED>Dystonia; Huntington disease; Nervous system diseases; Dopamine; Emission tomography; Positron emission tomography</ED>
<EG>Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Degenerative disease; Genetic disease; Central nervous system disease; Catecholamine; Neurotransmitter</EG>
<SD>Distonía; Corea Huntington; Sistema nervioso patología; Dopamina; Tomocentelleografía; Tomografía emisión positrones</SD>
<LO>INIST-20953.354000191622890040</LO>
<ID>11-0264645</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000579 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000579 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0264645
   |texte=   Milestones in Neuroimaging
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024